Visit 1 | Visit 3 | ||
---|---|---|---|
Pre-ozone | Post-Baseline Ozone | ||
Viability | % | 85.2 (9.4) | 89.3 (11.3) |
TCC | 106/mL | 1.5 (0.9) | 3.8 (3.6)*** |
WBC | 106/mL | 1.5 (1.0) | 3.7 (3.8)*** |
Macrophages | % nSq | 70.2 (22.6) | 25.2 (21.9)*** |
% WBC | 72.2 (28.0) | 25.5 (23.7)*** | |
cells/g | 1.0 (0.6) | 0.7 (1.0) | |
CD14+ Monocytes | % nSq | 1.9 (1.9) | 5.7 (2.4)*** |
% WBC | 1.9 (2.0) | 5.7 (2.1)*** | |
cells/g | 0.0 (0.1) | 0.2 (0.2)*** | |
Neutrophils | % nSq | 23.6 (21.6) | 64.5 (27.3)*** |
% WBC | 24.4 (23.5) | 67.0 (24.8)*** | |
cells/g | 0.2 (0.6) | 2.2 (2.4)*** | |
Lymphocytes | % nSq | 1.5 (1.6) | 0.6 (1.2)* |
%WBC | 1.7 (1.5) | 0.6 (1.2)* | |
cells/g | 0.0 (0.0) | 0.0 (0.1) | |
Eosinophils | % nSq | 0.0 (0.5) | 0.3 (0.5) |
% WBC | 0.0 (0.5) | 0.3 (0.6) | |
cells/g | 0.0 (0.0) | 0.0 (0.0) | |
Epithelial cells | % nSq | 1.4 (4.9) | 1.2 (1.4) |
cells/g | 0.0 (0.1) | 0.0 (0.0) | |
Squamous cells | % | 13.5 (16.2) | 3.8 (8.2) |
IL8 | pg/ml | 639.6 (496.5) | 1101.8 (723.1)*** |
IL6 | pg/ml | 13.1 (9.1) | 39.9 (49.4)*** |
IL1B | pg/ml | 22.8 (20.3) | 36.2 (40.5)*** |
MMP9 | ng/ml | 50.9 (71.6) | 152.6 (168.5)*** |